review article | Q7318358 |
scholarly article | Q13442814 |
P356 | DOI | 10.2217/FMB.09.43 |
P698 | PubMed publication ID | 19659421 |
P50 | author | Michael F. Good | Q6830168 |
Ashraful Haque | Q39049681 | ||
P2860 | cites work | Pfmdr1 copy number and arteminisin derivatives combination therapy failure in falciparum malaria in Cambodia | Q21034146 |
Efficacy of RTS,S/AS01E vaccine against malaria in children 5 to 17 months of age | Q24658073 | ||
Estimation of the total parasite biomass in acute falciparum malaria from plasma PfHRP2 | Q24814830 | ||
Sequence of Plasmodium falciparum chromosomes 1, 3-9 and 13 | Q27972532 | ||
Sequence of Plasmodium falciparum chromosomes 2, 10, 11 and 14 | Q27972535 | ||
Protection of humans against malaria by immunization with radiation-attenuated Plasmodium falciparum sporozoites | Q28212476 | ||
A role for natural regulatory T cells in the pathogenesis of experimental cerebral malaria | Q30479825 | ||
The Plasmodium sporozoite survives RTS,S vaccination | Q33221951 | ||
Evidence of blood stage efficacy with a virosomal malaria vaccine in a phase IIa clinical trial | Q33317265 | ||
Plasmodium falciparum antigens on the surface of the gametocyte-infected erythrocyte | Q33338492 | ||
Failure of artesunate-mefloquine combination therapy for uncomplicated Plasmodium falciparum malaria in southern Cambodia | Q33399259 | ||
Rationale and plans for developing a non-replicating, metabolically active, radiation-attenuatedPlasmodium falciparumsporozoite vaccine | Q34264618 | ||
Structural basis of antigenic escape of a malaria vaccine candidate | Q35927982 | ||
Allelic forms of gp195, a major blood-stage antigen of Plasmodium falciparum, are expressed in liver stages | Q36354328 | ||
Functional deficit of T regulatory cells in Fulani, an ethnic group with low susceptibility to Plasmodium falciparum malaria | Q36392966 | ||
Human cerebral malaria and the blood-brain barrier | Q36449710 | ||
Correctly folded Pfs48/45 protein of Plasmodium falciparum elicits malaria transmission-blocking immunity in mice | Q36670217 | ||
Effective induction of high-titer antibodies by viral vector vaccines | Q36770379 | ||
Memory CD8 T cell responses exceeding a large but definable threshold provide long-term immunity to malaria | Q36893651 | ||
Malaria: mechanisms of erythrocytic infection and pathological correlates of severe disease | Q37014714 | ||
Molecular surveillance for multidrug-resistant Plasmodium falciparum, Cambodia | Q37028467 | ||
Recombinant viral vaccines expressing merozoite surface protein-1 induce antibody- and T cell-mediated multistage protection against malaria | Q37146236 | ||
Reduced efficacy of insecticide-treated nets and indoor residual spraying for malaria control in pyrethroid resistance area, Benin | Q37302684 | ||
Attenuated Plasmodium yoelii lacking purine nucleoside phosphorylase confer protective immunity. | Q37608794 | ||
Immunity to malaria after administration of ultra-low doses of red cells infected with Plasmodium falciparum | Q39362892 | ||
Upregulation of TGF-beta, FOXP3, and CD4+CD25+ regulatory T cells correlates with more rapid parasite growth in human malaria infection | Q39571557 | ||
An extremely diverse CD4 response to vaccinia virus in humans is revealed by proteome-wide T-cell profiling. | Q39764626 | ||
Vaccination with live Plasmodium yoelii blood stage parasites under chloroquine cover induces cross-stage immunity against malaria liver stage | Q41337172 | ||
Protective T cell immunity against malaria liver stage after vaccination with live sporozoites under chloroquine treatment | Q41914565 | ||
Sequence of Plasmodium falciparum chromosome 12. | Q46412466 | ||
The hope but challenge for developing a vaccine that might control malaria | Q47640667 | ||
Real-time in vivo imaging of transgenic bioluminescent blood stages of rodent malaria parasites in mice. | Q47829228 | ||
Allelic polymorphisms in apical membrane antigen-1 are responsible for evasion of antibody-mediated inhibition in Plasmodium falciparum | Q47864459 | ||
Regulation of CD8+ T cells undergoing primary and secondary responses to infection in the same host. | Q52008043 | ||
What messenger RNA capping tells us about eukaryotic evolution. | Q55036001 | ||
P433 | issue | 6 | |
P921 | main subject | malaria vaccine | Q6741353 |
malaria | Q12156 | ||
P1104 | number of pages | 6 | |
P304 | page(s) | 649-654 | |
P577 | publication date | 2009-08-01 | |
P1433 | published in | Future Microbiology | Q15759961 |
P1476 | title | Malaria vaccine research: lessons from 2008/9. | |
P478 | volume | 4 |
Q37771945 | TLR9 and endogenous adjuvants of the whole blood-stage malaria vaccine | cites work | P2860 |
Search more.